MOU 225-17-019
I. PURPOSE
The Food and Drug Administration (FDA) and the Bill & Melinda Gates Foundation (BMGF) (each a “Party” and collectively the “Parties”) share interests in scientific progress related to regulatory science and regulatory capacity building in support of advancing global public health. This memorandum of understanding (MOU) establishes a framework for collaboration between FDA and the BMGF to facilitate existing and new mutually agreed upon programs and activities and to carry out their common goal to improve public health by stimulating and fostering medical product innovation and enabling medical product development. Read more